Concurrent treatment with an ACE inhibitor may amplify the utility of calcium supplementation for control of hypertension
- 31 December 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 63 (5) , 818-822
- https://doi.org/10.1016/j.mehy.2002.11.001
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomyPublished by Oxford University Press (OUP) ,2000
- Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomySurgery, 1999
- Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humansNephrology Dialysis Transplantation, 1997
- Clinical Aspects of Parathyroid Hypertensive FactorJournal of Cardiovascular Pharmacology, 1994
- Parathyroid hypertensive factor-like activity in human essential hypertensionJournal Of Hypertension, 1993
- Calcium and sodium handling during volume expansion in essential hypertensionMetabolism, 1993
- Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failureKidney International, 1993
- Long‐term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertensionWorld Journal of Surgery, 1992
- Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long‐term treatment with active vitamin D (Alphacalcidol)Journal of Internal Medicine, 1992
- Hypertension in Primary Hyperparathyroidism--Reduction of Blood Pressure by Long-Term Treatment With Vitamin D (Alphacalcidol): A Double-Blind, Placebo-Controlled StudyAmerican Journal of Hypertension, 1988